MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$22,141K
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Annual
123
Page 1
Income Statement
2025-12-31
General and administrative
7,585
Impairment of long-lived assets
854
Total operating expenses
8,439
Operating loss
-8,439
Non-cash (loss) gain on changes in fair value of warrant liability
24,486
Accretion of interest and amortization of discounts on convertible notes
277
Other expense, net
-20
Net loss from continuing operations
-33,222
Net income from discontinued operations, net of taxes
11,081
Net loss
-22,141
Less increase to accumulated deficit due to adjustment to common stock warrant exercise price
0
Less increase to accumulated deficit due to adjustment to preferred stock conversion price
0
Net loss attributable to common stockholders
-22,141
Basic EPS
-3.8
Basic Average Shares
5,820,000
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS).
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
attributable to common...
-$22,141K
Net loss
-$22,141K
Net income from
discontinued operations, net...
$11,081K
Net loss from
continuing operations
-$33,222K
Non-cash (loss) gain on
changes in fair value of...
$24,486K
Operating loss
-$8,439K
Accretion of interest and
amortization of discounts on...
$277K
Other expense, net
-$20K
Total operating
expenses
$8,439K
General and
administrative
$7,585K
Impairment of long-lived
assets
$854K
Buy us a coffee
NovaBay Pharmaceuticals, Inc. (NBY)
NovaBay Pharmaceuticals, Inc. (NBY)